|
|
|
|
| LEADER |
01268nam a22001457a 4500 |
| 008 |
130119b xxu||||| |||| 00| 0 eng d |
| 082 |
|
|
|a 615.19
|
| 245 |
|
|
|a New frontiers in drug design,discovery and development :
|b proceedings of the seventeenth annual symposium held at National Institute of Immunology New Delhi on February 11, 2011 /
|c Edited by R.K.Jalali
|
| 260 |
|
|
|a New Delhi :
|b Ranbaxy science foundation,
|c 2011.
|
| 300 |
|
|
|a 122p. ;
|c 25 cm.
|
| 505 |
|
|
|a Development of antihypertensive drugs that inhibit the Renin-Angiotensin system--Genomes to hits--Novel peptidomimetics--Appraoches towards the development of a chimeric DPP4/ACE inhibitor for treating metabolic syndrome--Importance of chemical and biological space--Improving productivity in research & development--New approaches to the development of antibacterial agent with special reference to quinolone drug discovery leading to ofloxacin, levofloxacin and sitafloxacin--Heat shock protein 90 as a drug target against protzoan infections--Challenge of drug development--New drug development--Repositioning of discovered drugs.
|
| 650 |
|
|
|a Drugs
|x Design
|
| 942 |
|
|
|c BK
|
| 999 |
|
|
|c 97970
|d 97970
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_190000000000000_NEW
|7 0
|9 97397
|a UL
|b UL
|c PROC
|d 2013-01-19
|l 0
|o 615.19 NEW
|p G10095
|r 2013-01-19
|y BK
|